Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_assertion type Assertion NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_head.
- NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_assertion description "[Gene-specific quantitative multiplex polymerase chain reaction of candidate oncogenes at 1q32.1 (KIF14), 6p22 (E2F3 and DEK), and tumor suppressor genes at 16q22 (CDH11) and 17q21 (NGFR) showed the most common gene gains in RB to be KIF14 in cell lines (80%) and E2F3 in primary tumors (70%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_provenance.
- NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_assertion evidence source_evidence_literature NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_provenance.
- NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_assertion SIO_000772 17099872 NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_provenance.
- NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_assertion wasDerivedFrom befree-20140225 NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_provenance.
- NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_assertion wasGeneratedBy ECO_0000203 NP633360.RApXHyZmaCFqvDlS1QS2L1GacKH-ElLbq9zvriTX4MlYo130_provenance.